Bentham Science Logo

Track Your Manuscript:


Recent Patents on Anti-Cancer Drug Discovery

Volume 15, 4 Issues, 2020
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery

,

Volume 15

-

Number 1



Biography   Open Access



Review Article (Mini-Review)

Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years

, 15(1): 2 - 13

Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo and Xiukun Lin*


DOI: 10.2174/1574892815666200131120618


Review Article



Review Article



Research Article



Research Article

Increased NID1 Expression among Breast Cancer Lung Metastatic Women; A Comparative Analysis between Naive and Treated Cases

, 15(1): 59 - 69

Tabinda Urooj*, Bushra Wasim, Shamim Mushtaq, Ghulam Haider, Syed N.N. Shah, Rubina Ghani and Muhammad F.H. Qureshi


DOI: 10.2174/1574892815666200302115438


Research Article



Research Article



Articles Ahead of Print

Cancer Stem Cells and their Management in Cancer Therapy


Suzan Shenouda, Ketan Kulkarni, Yasser Abuetabh and Consolato Sergi *


DOI: 10.2174/1574892815666200713145931
View Abstract View on PubMed


Anticancer Potential of Aguerin B, a Sesquiterpene Lactone Isolated from Centaurea behen in Metastatic Breast Cancer Cells


Elaheh Amini, Mohammad Nabiuni, Seyed Bahram Behzad, Danial Seyfi, Farhad Eisvand, Amirhossein Sahebkar* and Abolfazl Shakeri


DOI: 10.2174/1574892815666200713162304
View Abstract View on PubMed


Developments in the Application of 1,2,3-Triazoles in Cancer Treatment


Katerina I. Slavova, Lozan T. Todorov*, Nataliya P. Belskaya, Mauricio Alcolea Palafox and Irena P. Kostova


DOI: 10.2174/1574892815666200717164457
View Abstract View on PubMed


The JPJDF has Synergistic Effect with Fluoropyrimidine in the Maintenance Therapy for Metastatic Colorectal Cancer


XiaoLing Fu*, YanBo Zhang, Lisheng Chang, DengCheng Hu, Ru Jia, NingNing Liu, HuaYue Zhang, Gang Han, ZhiFen Han, Yuan Li, Hui Liu, Huirong Zhu and Qi Li


DOI: 10.2174/1574892815666200717141205
View Abstract View on PubMed







The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX


Ijaz Muhammad, Noor Rahman, Gul E Nayab, Sadaf Niaz, Mohibullah Shah, Sahib Gul Afridi, Haroon Khan*, Maria Daglia and Esra Capanoglu


DOI: 10.2174/1574892815666200226112506
View Abstract View on PubMed


Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Published Contents

Editor's Choice

Feasibility of Repurposing Clioquinol for Cancer Therapy

, 2020; 15(1): 14 - 31

Raheel Khan, Harras Khan, Yassen Abdullah and Q. Ping Dou*


DOI: 10.2174/1574892815666200227090259




HMGA and Cancer: A Review on Patent Literatures

, 2019; 14(3): 258 - 267

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827



PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256







Open Access Articles


From Antimicrobial to Anticancer Peptides: The Transformation of Peptides

, 2019; 14(1): 70 - 84

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*





New Anti-Cancer Strategies in Testicular Germ Cell Tumors

, 2019; 14(1): 53 - 59

Paolo Chieffi*, Marco De Martino and Francesco Esposito




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*




Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

, 2019; 14(1): 39 - 52

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*




Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment

, 2019; 14(1): 32 - 38

Giorgia Scarpellino, Tullio Genova and Luca Munaron*




Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds

, 2019; 14(1): 19 - 31

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*




Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*





Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

, 2018; 13(4): 422 - 427

Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*




Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*





Most Cited Articles

Review Article

Repurposing disulfiram as an anti-cancer agent: Updated review on literature and patents

, 2019; 14(2): 113-132.

Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*


DOI: 10.2174/1574892814666190514104035


Review Article

Tobacco smoking: Risk to develop addiction, chronic obstructive pulmonary disease, and lung cancer

, 2019; 14(1): 39-52.

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*


DOI: 10.2174/1574892814666190102122848



Review Article

New anti-cancer strategies in testicular germ cell tumors

, 2019; 14(1): 53-59.

Paolo Chieffi*, Marco De Martino and Francesco Esposito


DOI: 10.2174/1574892814666190111120023


Research Article

A truncated snail1 transcription factor alters the expression of essential EMT markers and suppresses tumor cell migration in a human lung cancer cell line

, 2019; 14(2): 158-169.

Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*


DOI: 10.2174/1574892814666190527111429


Review Article

Tocotrienols and cancer: From the state of the art to promising novel patents

, 2019; 14(1): 5-18.

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827


Review Article

Purinergic P2X7 receptor: A cation channel sensitive to tumor microenvironment

, 2019; 14(1): 32-38.

Giorgia Scarpellino, Tullio Genova and Luca Munaron*


DOI: 10.2174/1574892814666190116122256


Review Article

From antimicrobial to anticancer peptides: The transformation of peptides

, 2019; 14(1): 70-84.

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*


DOI: 10.2174/1574892814666190119165157


General Review Article

HMGA and cancer: A review on patent literatures

, 2019; 14(3): 258-267.

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001



Review Article

Contemporary formulations for drug delivery of anticancer bioactive compounds

, 2019; 14(1): 19-31.

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*


DOI: 10.2174/1574892814666190111104834


Review Article

MDM2-P53 interaction inhibitors: The current state-of-art and updated patent review (2010-present)

, 2019; 14(4): 324-369.

Rafał Rusiecki, Jakub Witkowski* and Jaszczewska-Adamczak Joanna


DOI: 10.2174/1574892814666191022163540


Review Article (Mini-Review)

Alkaloids as anticancer agents: A review of chinese patents in recent 5 years

, 2020; 15(1): 2-13.

Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo and Xiukun Lin*


DOI: 10.2174/1574892815666200131120618



Research Article

Enzyme and transporter kinetics for CPT-11 (Irinotecan) and SN-38: An insight on tumor tissue compartment pharmacokinetics using PBPK

, 2019; 14(2): 177-186.

Yingfang Fan, Najia Mansoor*, Tasneem Ahmad, Zhuo X. Wu, Rafeeq A. Khan, Martin Czejka, Syed Sharib, Mansoor Ahmed, Zhe S. Chen and Dong H. Yang*


DOI: 10.2174/1574892814666190212164356



Most Accessed Articles


Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211





Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy

, 2006; 1(1): 39-53.

Victoria Cepeda, Miguel A. Fuertes, Josefina Castilla, Carlos Alonso, Celia Quevedo, Manual Soto and Jose M. Perez


DOI: 10.2174/157489206775246430


PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392-410.

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256



Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years

, 2020; 15(1): 2-13.

Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo and Xiukun Lin*


DOI: 10.2174/1574892815666200131120618




Editor-in-Chief

Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)
Biography
View Full Editorial Board

Journal History

Recent Patents on Anti-Cancer Drug Discovery was launched in 2006. Prof. Zhe-Sheng (Jason) Chen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.52

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog